Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated.
Billheimer JT, Dicker IB, Wynn R, Bradley JD, Cromley DA, Godonis HE, Grimminger LC, He B, Kieras CJ, Pedicord DL, Spitz SM, Thomas BE, Zolotarjova NI, Gorko MA, Hollis GF, Daly RN, Stern AM, Seiffert D.
Billheimer JT, et al. Among authors: hollis gf.
Blood. 2002 May 15;99(10):3540-6. doi: 10.1182/blood.v99.10.3540.
Blood. 2002.
PMID: 11986205
Free article.